Does FOSCARNET Cause Product use in unapproved indication? 102 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 102 reports of Product use in unapproved indication have been filed in association with FOSCARNET (Foscarnet Sodium). This represents 5.0% of all adverse event reports for FOSCARNET.
102
Reports of Product use in unapproved indication with FOSCARNET
5.0%
of all FOSCARNET reports
23
Deaths
23
Hospitalizations
How Dangerous Is Product use in unapproved indication From FOSCARNET?
Of the 102 reports, 23 (22.5%) resulted in death, 23 (22.5%) required hospitalization, and 7 (6.9%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSCARNET. However, 102 reports have been filed with the FAERS database.
What Other Side Effects Does FOSCARNET Cause?
Off label use (610)
Drug ineffective (368)
Drug resistance (309)
Acute kidney injury (246)
Cytomegalovirus infection (200)
Nephropathy toxic (198)
Pathogen resistance (190)
Renal impairment (184)
Pancytopenia (170)
Cytomegalovirus infection reactivation (167)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which FOSCARNET Alternatives Have Lower Product use in unapproved indication Risk?
FOSCARNET vs FOSFOMYCIN
FOSCARNET vs FOSFOMYCIN TROMETHAMINE
FOSCARNET vs FOSINOPRIL
FOSCARNET vs FOSPHENYTOIN
FOSCARNET vs FOSTAMATINIB